Aurobindo Pharma share news, announcements and annual reports
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Aurobindo Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Jul 2000 on NSE
Last close ₹1,681.40up ₹21.50 (1.30%)BSE ₹1,677.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,659.90.
30 Oct: open ₹1,652.00, high ₹1,687.00, low ₹1,647.20
52-week range of traded prices to 30 Oct 2026
₹1,091.20Low, 30 Oct 2025₹1,740.00High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹96,744 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.06
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,65057.5% delivered
Aurobindo Pharma orders, deals and press releases
463 filed, newest first. Page 8 of 10.
Feb 2010
26 Feb · Business
Press release dated February 25, 2010, titled "Aurobindo Pharma receives tentative approval for its New Drug Application (NDA) Nevirapine Tablets for Oral Suspension 50mg". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Feb · Business
Aurobindo Pharma Ltd had informed the Exchange regarding the Scheme of Amalgamation of Trident Life Sciences Limited with Aurobindo Pharma Limited and their respective Shareholders. The Company has now informed the Exchange that "As directed by the Hon'ble High Court of Judicature of Andhra Pradesh at Hyderabad by its Order dated 19th February, 2010, the Company, on February 24, 2010, has published the notice in News Papers of the date of hearing of the petition on 19th March, 2010 for the sanction of the Scheme of Amalgamation of Trident Life Sciences Limited with Aurobindo Pharma Limited and their respective Shareholders".4 Feb · Business
Press release dated February 04, 2010, titled "Aurobindo Pharma receives final approval for Cetirizine Hydrochloride Solution (OTC)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2010
30 Jan · Business
Press release dated January 30,2010 titled " Aurobindo Pharma Q3 2009-10 Unaudited Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2009
17 Dec · Business
Press release dated December 17, 2009, titled "Aurobindo Pharma receives final approval for Cetirizine Hydrochloride Syrup (Rx)". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Dec · Business
Press release dated December 15, 2009, titled "Aurobindo Pharma receives approval for Citalopram Hydrobromide tablets from TGA, Australia". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2009
23 Nov · Business
Press release dated November 23, 2009, titled "Aurobindo Pharma celebrates the inauguration of its formulations manufacturing facility (Unit VII) in Special Economic Zone, Hyderabad India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Nov · Business
Press release dated November 12, 2009, titled "Aurobindo Pharma receives final approval for Perindopril Erbumine Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Nov · Business
Press release dated November 09, 2009, titled "Aurobindo Pharma receives final approval for Cefotaxime for Injection USP". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Nov · Business
Press release dated November 06, 2009, titled "Aurobindo Pharma receives final approval for Lamotrigine Tablets from USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
30 Oct · Business
Press release dated October 30, 2009, titled "Aurobindo Pharma Q2 2009-10 Unaudited Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Oct · Business
Press release dated October 29, 2009, titled "Aurobindo Pharma receives two registrations from MCC-South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
29 Sep · Business
Press release dated September 29, 2009, titled "Aurobindo Pharma receives prestigious Export Performance Award from Pharmexcil". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Sep · Business
Press release dated September 18, 2009, titled "Aurobindo Pharma receives three ANDA approvals from USFDA for Atomoxetine Hydrochloride Capsules, Ribavirin Tablets and Ribavirin Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Sep · Business
Press release dated September 07, 2009, titled "Aurobindo Pharma receives final approval for Risperidone Oral Solution". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Sep · Business
Press release dated September 07, 2009, titled "Aurobindo Pharma receives Swissmedic approvals for Amlodipine Besylate Tablets and Metformin Hydrochloride Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
27 Aug · Business
Press release dated August 27, 2009, titled "Aurobindo Pharma receives final approval for Clindamycin Hydrochloride Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Aug · Business
Press release dated August 27, 2009, titled "Aurobindo Pharma receives Swissmedic approval for Cefepime for Injection". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Aug · Business
Vide its letter dated August 14, 2009, that: "The Board of Directors of Aurobindo Pharmaceuticals Limited ("APL") today approved the proposal to acquire 100% stake of Trident Life Sciences Limited ("TLSL") subject to suitable agreements being executed between the parties for the same and conditions customary to closing of the transaction". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Aug · Business
Press release dated August 11, 2009, titled "Aurobindo Pharma receives final approval for Sumatriptan Succinate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Aug · Business
Press release dated August 07, 2009, titled "Aurobindo Pharma receives its 100th ANDA approval from USFDA for Carisoprodol Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
31 Jul · Business
Press release dated July 31, 2009, titled "Aurobindo Pharma Q1 2009-10 Unaudited Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jul · Business
Press release dated July 29, 2009, titled "Aurobindo Pharma receives tentative approval for Donepezil Hydrochloride Tablets from USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Jul · Business
Press release dated July 24, 2009 titled "Aurobindo Pharma's New Drug Applications Zidovudine Tablets 60mg and Lamivudine & Zidovudine Tablets 30mg/60mg receives USFDA Approvals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Jul · Business
Press release dated July 10, 2009 titled "Aurobindo Pharma receives final approval for Fosinopril Sodium and Hydrochlorothiazide Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
18 Jun · Business
With reference to the earlier announcements dated 31st March, 2009 and 22nd May, 2009 regarding the Scheme of Arrangement between Aurobindo Pharma Limited and its Shareholders, it is now informed that as directed by the Hon'ble High Court of Judicature of Andhra Pradesh at Hyderabad by its Order dated 16th June, 2009, the Company, on 18th June 2009, has published the notice in News Papers about the date of hearing of the petition for the sanction of the Scheme of Arrangement between Aurobindo Pharma Limited and its Shareholders15 Jun · Business
Press release dated June 15, 2009 titled "Aurobindo Pharma receives approval for Amlodipine Besylate Tablets from TGA, Australia". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
29 May · Business
Press release dated May 29, 2009 titled "Aurobindo Pharma's US Joint Venture receives original generic approval for Ceftiofur Sodium Sterile Powder". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 May · Business
Press release dated May 21, 2009 titled "Aurobindo Pharma expands Licensing and Supply Agreement with Pfizer". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
30 Apr · Business
Press release dated April 30, 2009 titled "FY 2008-09 and Q4 2008-09 Unaudited Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Apr · Business
Press release dated April 08, 2009 titled "Aurobindo Pharma receives first product approval from Swissmedic for Finasteride Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2009
31 Mar · Business
Press release dated March 31, 2009 titled "Aurobindo Pharma receives tentative approval for Emtricitabine / Tenofovir Disproxil Fumarate Tablets ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.31 Mar · Business
The Board of Directors of the Company approved the Scheme of Arrangement ("the Scheme") in their meeting held on March 31, 2009, which inter alia provides for the following: 1) Utilization of the Capital Redemption Reserve Account of Rs. 90.0 million outstanding as on March 31, 2008. 2) The gains arising on the buyback of FCCBs, being capital in nature, together with the amount of Rs. 90.3 million standing to the credit of Capital Reserve Account as on March 31, 2008 shall be credited to "Reconstruction Reserve Account". 3) The Capital Redemption Reserve Account and the Reconstruction Reserve Account shall be utilized at the discretion of the Board for adjusting the expenses of the nature such as diminution in value of investments, impairment of goodwill / assets etc., as would be described in the Scheme. 4) The scheme does not entail issue of any shares or other consideration to any of its shareholders. The Scheme is subject to requisite consent, approval of the requisite majority of the shareholders of the Company, the Hon'ble High Court of Judicature at Hyderabad, Stock Exchanges, the permission or approval of any other statutory or regulatory authorities, which by law may be necessary for the implementation of the Scheme.30 Mar · Business
Press release dated March 30, 2009 titled "Aurobindo Pharma receives final approval for Topiramate Tablets ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Mar · Business
Press release dated March 20, 2009 titled "Aurobindo Pharma receives second product approval from TGA, Australia for Sertraline Tablets ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Mar · Business
Press release dated March 20, 2009 titled "Aurobindo Pharma receives final approval for Fluoxetine Oral Solution". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Mar · Business
Press release dated March 18, 2009 titled "Aurobindo Pharma receives three new registrations from MCC- South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Mar · Business
Press release dated March 12, 2009 titled "Aurobindo Pharma receives tentative approval for Lopinavir/Ritonavir Tablets." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Mar · Business
Press release dated March 04, 2009 titled "Aurobindo Pharma receives tentative approval for Escitalopram Oxalate Tablets." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Mar · Business
Press release dated March 03, 2009 titled "Aurobindo Pharma Announces Licensing and Supply Agreement with Pfizer for Supply of Finished Dosage Products." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Mar · Business
Press release dated March 02, 2009 titled "Aurobindo Pharma receives first product approval from TGA, Australia for Lisinopril (as dihydrate) Tablets." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
20 Feb · Business
Press release dated February 20, 2009 titled "Aurobindo Pharma receives tentative approval for Tenofovir Disoproxil Fumarate Tablets." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
30 Jan · Business
Press release dated January 30, 2009 titled "Q3 FY 2008-09 Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jan · Business
Press release dated January 30, 2009, titled "Q3 FY2008-09 Results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jan · Business
Press release dated January 16, 2009, titled "Aurobindo Pharma receives final approval for Levetiracetam tablets and oral solution". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Jan · Business
Press release dated January 06, 2009, titled "Aurobindo Pharma receives approval for Gabapentin Capsules from Health Canada ." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
31 Dec · Business
Press release dated December 31, 2008, titled "Aurobindo Pharma receives final approval for Stavudine Capsules and Oral Solution." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Dec · Business
Press release dated December 24, 2008, titled "Aurobindo Pharma receives approval for Terbinafine Tablets from Health Canada". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Dec · Business
Press release dated December 22, 2008, titled "Aurobindo Pharma receives four new registrations from MCC- South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Dec · Business
Press release dated December 22, 2008, titled "Aurobindo Pharma receives tentative approval for its New Drug Application (NDA) Abacavir Sulfate / Lamivudine Tablets 60/30mg". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.